Magnetic resonance imaging of the thalamus in male patients with schizophrenia

Schizophrenia Research

Volumn 58, Issue 2-3, 2002, Pages 135-144

  Deicken, Raymond F ^a,b   Eliaz, Yael ^a   Chosiad, Lynn ^a   Feiwell, Robert ^b   Rogers, Linda ^a  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brain; Magnetic resonance imaging; Psychosis; Schizophrenia; Thalamus

Indexed keywords

ADULT; ARTICLE; BRAIN SIZE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; GRAY MATTER; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCHIZOPHRENIA; THALAMUS;

ADULT; ANTIPSYCHOTIC AGENTS; FUNCTIONAL LATERALITY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; THALAMUS;

EID: 0036888339     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(01)00330-9     Document Type: Article

References (41)

1. Andreasen N.C., Arndt S., Swayze V. II, Cizadio T., Flaum M., O'Leary D., Ehrhardt J.C., Yuh W.T.C. Thalamic abnormalities in schizophrenia visualized through magnetic resonance imaging averaging. Science. 266:1994;294-298.
2. Annett M.M. A classification of hand preference by association analysis. Br. J. Psychology. 61:1970;303-321.
3. Arciniegas D., Rojas D.C., Teale P., Sheeder J., Sandberg E., Reite M. The thalamus and the schizophrenia phenotype: failure to replicate reduced volume. Biol. Psychiatry. 45:1999;1329-1335.
4. Arndt S., Andreasen N.C., Cizadlo T., O'Leary D.S., Swayze V.W., Cohen G. Evaluating and validating two methods for estimating brain structure volumes: tessellation and simple pixel counting. NeuroImage. 1:1994;191-198.
5. Buchsbaum M.S., Someya T., Teng C.Y., Abel L., Chin S., Najafi A., Haier R.J., Wu J., Bunney W.E. Jr. PET and MRI of the thalamus in never medicated patients with schizophrenia. Am. J. Psychiatry. 153:1996;191-199.
6. Byne W., Buchsbaum M.S., Kemether E., Hazlett E.A., Shinwari A., Mitropoulou M.A., Siever L.J. Magnetic resonance imaging of the thalamic mediodorsal nucleus and pulvinar in schizophrenia and schizotypal personality disorder. Arch. Gen. Psychiatry. 58:2001;133-140.
7. Corey-Bloom J., Jernigan T., Archibald S., Harris M.J., Jeste D.V. Quantitative magnetic resonance imaging of the brain in late life schizophrenia. Am. J. Psychiatry. 152:1995;447-449.
8. Crow T.J. Schizophrenia as an anomaly of cerebral asymmetry. Maurer K. Imaging of the Brain in Psychiatry and Related Fields. 1993;3-17 Springer, Berlin.
9. Crow T.J. Schizophrenia as failure of hemispheric dominance for language. Trends Neurosci. 20:1997;339-343.
10. Danos P., Baumann B., Bernstein H.G., Franz M., Stauch R., Northoff G., Krell D., Falkai P., Bogerts B. Schizophrenia and anteroventral thalamic nucleus: selective decrease of parvalbumin-immunoreactive thalamocortical projection neurons. Psychiatry Res.: Neuroimaging. 82:1998;1-10.
11. Deicken R.F., Johnson C., Eliaz Y., Schuff N. Reduced concentrations of thalamic N-acetylaspartate in male patients with schizophrenia. Am. J. Psychiatry. 157:2000;644-647.
12. Easterbrook P.J., Berlin J.A., Gopalan R., Matthews D.R. Publication bias in clinical research. Lancet. 337:1991;867-872.
13. Ende G., Braus D.F., Walter S., Henn F.A. Lower concentrations of thalamic N-acetylaspartate in patients with schizophrenia: a replication study. Am. J. Psychiatry. 158:2001;1314-1316.
14. Flaum M., Swayze V.W. II, O'Leary D.S., Yuh W.T.C., Ehrhardt J.C., Arndt S.V., Andreasen N.C. Effects of diagnosis, laterality, and gender on brain morphology in schizophrenia. Am. J. Psychiatry. 152:1995;702-714.
15. Frazier J., Giedd J., Hamburger S., Albus K., Kaysen D., Vaituzis A., Rajapakse J., Lenane M., McKenna K., Jacobsen L., Gordon C., Breier A., Rapoport J. Brain anatomic magnetic resonance imaging in childhood-onset schizophrenia. Arch. Gen. Psychiatry. 53:1996;617-624.
16. Gilbert A.R., Rosenberg D.R., Harenski K., Spencer S., Sweeney J.A., Keshavan M.S. Thalamic volumes in patients with first-episode schizophrenia. Am. J. Psychiatry. 158:2001;618-624.
17. Gur R.E., Maany V., Mozley D., Swanson C., Bilker W., Gur R.C. Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia. Am. J. Psychiatry. 155:1998;1711-1717.
18. Hazlett E.A., Buchsbaum M.S., Byne W., Wei T.C., Spiegel-Cohen J., Geneve C., Kinderlehrer R., Haznedar M.M., Shihabuddin L., Siever L.J. Three-dimensional analysis with MRI and PET of the size, shape, and function of the thalamus in the schizophrenia spectrum. Am. J. Psychiatry. 156:1999;1190-1199.
19. Jeste D.V., McAdams L.A., Palmer B.W., Braff D., Jernigan T.L., Paulsen J.S., Stout J.C., Symonds L.L., Bailey A., Heaton R.K. Relationship of neuropsychological and MRI measures to age of onset of schizophrenia. Acta Psychiatr. Scand. 98:1998;156-164.
20. Kling A.S., Metter E.J., Riege W.H., Kuhl D.E. Comparison of PET measurement of local brain glucose metabolism and CAT measurement of brain atrophy in chronic schizophrenia and depression. Am. J. Psychiatry. 143:1986;175-180.
21. Konick L.C., Friedman L. Meta-analysis of thalamic size in schizophrenia. Biol. Psychiatry. 49:2001;28-38.
22. Lawrie S.M., Whalley H., Kestelman J.N., Abukmeil S.S., Byrne M., Hodges A., Rimmington J.E., Best J.J., Owens D.G., Johnstone E.C. Magnetic resonance imaging of brain in people at high risk of developing schizophrenia. Lancet. 353:1999;30-33.
23. Lesh A., Bogerts B. The diencephalon in schizophrenia: evidence for reduced thickness of the periventricular grey matter. Eur. Arch. Psychiatry Neurol. Sci. 234:1984;212-219.
24. Omori M., Murata T., Kimura H., Koshimoto Y., Kado H., Ishimori Y., Ito H., Wada Y. Thalamic abnormalities in patients with schizophrenia revealed by proton magnetic resonance spectroscopy. Psychiatry Res.: Neuroimaging. 98:2000;155-162.
25. Pakkenberg B. Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Arch. Gen. Psychiatry. 47:1990;1023-1028.
26. Pakkenberg B. The volume of the mediodorsal thalamic nucleus in treated and untreated schizophrenics. Schizophr. Res. 7:1992;95-100.
27. Popken G.J., Bunney W.E., Potkin S.G., Jones E.G. Subnucleus-specific loss of neurons in medial thalamus of schizophrenics. Proc. Natl. Acad. Sci. U. S. A. 97:2000;9276-9280.
28. Portas C.M., Goldstein L.M., Shenton M.E., Hokama H.H., Wible C.G., Fisher I., Kikins R., Donnino R., Jolesz F.A., McCarley R.W. Volumetric evaluation of the thalamus in schizophrenic male patients using magnetic resonance imaging. Biol. Psychiatry. 43:1998;649-659.
29. Preuss U., Zetsche T., Moller H.J., Meisenzahl E.M. MRI volumetry of the thalamus in schizophrenia. World J. Biol. Psychiatry. 2:2001;247S.
30. Resnick S.M., Gur R.E., Alavi A., Gur R.C., Reivich M. Positron emission tomography and subcortical glucose metabolism in schizophrenia. Psychiatry Res. 24:1988;1-11.
31. Rosenthal R., Bigelow L.B. Quantitative brain measurements in chronic schizophrenia. Br. J. Psychiatry. 121:1972;259-264.
32. Schuff N., Amend D.L., Meyerhoff D.J., Tanabe J.L., Norman D., Fein G., Weiner M.W. Alzheimer disease: quantitative H-1 MR spectroscopic imaging of frontoparietal brain. Radiology. 207:1998;91-102.
33. Seidman L.J., Faraone S.V., Goldstein J.M., Goodman J.M., Kremen W.S., Matsuda G., Hoge E.A., Kennedy D., Makris N., Cavines V.S., Tsuang M.T. Reduced subcortical brain volumes in nonpsychotic siblings of schizophrenic patients: a pilot magnetic resonance imaging study. Am. J. Med. Genet. 74:1997;507-514.
34. Siege B.V. Jr., Buchsbaum M.S., Bunney W.E. Jr., Gottschalk L.A., Haier R.J., Lohr J.B., Lottenberg S., Najafi A., Nuechterlein K.H., Potkin S.G., Wu J.C. Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients. Am. J. Psychiatry. 150:1993;1325-1336.
35. Staal W.G., Hulshoff Pol H.E., Schnack H., Van Der Schot A.C., Kahn R.S. Partial volume decrease of the thalamus in relatives of patients with schizophrenia. Am. J. Psychiatry. 155:1998;1784-1786.
36. Staal W.G., Hulshoff Pol H.E., Schnakc H., van Haren N.E.M., Seifert N., Kahn R.S. Am. J. Psychiatry. 158:2001;1140-1142.
37. Szechtman H.J., Nahmias C., Garnett E.S., Firnau G., Brown G.M., Kaplan R.D., Cleghorn J.M. Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia. Arch. Gen. Psychiatry. 45:1988;523-532.
38. Tanabe J., Amend D., Schuff N., Sclafani V.D., Ezekiel F., Norman D., Fein G., Weiner M.W. Tissue segmentation of the brain in Alzheimer's disease. Am. J. Neuroradiol. 18:1997;115-123.
39. Volz H.P., Gaser C., Sauer H. Supporting evidence for the model of cognitive dysmetria in schizophrenia - a structural magnetic resonance imaging study using deformation-based morphometry. Schizophr. Res. 46:2000;45-56.
40. Wiesel F.A., Blomqvist G., Greitz T., Nyman H., Schalling D., Stone-Elander S., Widen L., Wik G. Regional brain glucose metabolism in neuroleptic free schizophrenic patients in an acute phase of the disease. Shagass C., Josiassen R.C., Bridger W.H., Weiss K.J., Stoff D., Simpson G.M. Biological Psychiatry, Proceedings of the 4th World Congress of Biological Psychiatry, 1986. 1985;392-394 Elsevier, New York.
41. Young K.A., Manaye K.F., Liang C.L., Hicks P.B., German D.C. Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia. Biol. Psychiatry. 47:2000;944-953.